Advertisement

Effects of bovine lactoferrin hydrolysate on the in vitro antimicrobial susceptibility of Escherichia coli strains isolated from baby pigs

Po-Wen ChenDepartment of Veterinary Medicine, National Chung- Hsing University, Taichung, Taiwan, 40227, Republic of China.

Search for other papers by Po-Wen Chen in
Current site
Google Scholar
PubMed
Close
 DVM
,
Shu-Peng HoDepartment of Veterinary Medicine, National Chung- Hsing University, Taichung, Taiwan, 40227, Republic of China.

Search for other papers by Shu-Peng Ho in
Current site
Google Scholar
PubMed
Close
 PhD
,
Ching-Ling ShyuDepartment of Veterinary Medicine, National Chung- Hsing University, Taichung, Taiwan, 40227, Republic of China.

Search for other papers by Ching-Ling Shyu in
Current site
Google Scholar
PubMed
Close
 DVM
, and
Frank C. MaoDepartment of Veterinary Medicine, National Chung- Hsing University, Taichung, Taiwan, 40227, Republic of China.

Search for other papers by Frank C. Mao in
Current site
Google Scholar
PubMed
Close
 PhD

Abstract

Objective—To determine the antibacterial activity of bovine lactoferrin hydrolysate (bLf-lysate) alone or in combination with other antimicrobials against antimicrobial-resistant Escherichia coli strains isolated from baby pigs.

Sample Population—3 clinical strains of E coli were isolated from baby pigs with severe diarrhea and designated as strains 9061, 9062, and 9065.

Procedure—The broth microdilution checkerboard and fractional inhibitory (or bactericidal) concentration index were used to evaluate the antibacterial effect elicited by bLf-lysate in combination with kanamycin, gentamicin, cephalothin, cefamandole, penicillin G, ampicillin, tetracycline, erythromycin, or rifampicin against the 3 strains of E coli.

Results—The 3 strains of E coli were susceptible to gentamicin and rifampicin but highly resistant to most of the other antimicrobials tested, except for strain 9061 that was also susceptible to cephalothin but intermediately inhibited by kanamycin and cefamandole. Synergistic growth-inhibitory activity was observed between bLf-lysate and gentamicin against 1 strain of E coli (strain 9062); synergistic bactericidal activity was found between bLf-lysate and rifampicin against all 3 strains of E coli. Moreover, partial synergy was observed between bLf-lysate and kanamycin, gentamicin, cephalothin, or cefamandole against the strains of E coli, but this partial synergistic activity was mostly seen against only 1 of the strains. Little interaction between bLf-lysate and tetracycline, ampicillin, penicillin G, or erythromycin was observed against the clinical strains of E coli.

Conclusions and Clinical Relevance—A combination of bLf-lysate and certain antimicrobials may prove clinically effective against antimicrobial-resistant strains of E coli. (Am J Vet Res 2004;65:131–137)

Abstract

Objective—To determine the antibacterial activity of bovine lactoferrin hydrolysate (bLf-lysate) alone or in combination with other antimicrobials against antimicrobial-resistant Escherichia coli strains isolated from baby pigs.

Sample Population—3 clinical strains of E coli were isolated from baby pigs with severe diarrhea and designated as strains 9061, 9062, and 9065.

Procedure—The broth microdilution checkerboard and fractional inhibitory (or bactericidal) concentration index were used to evaluate the antibacterial effect elicited by bLf-lysate in combination with kanamycin, gentamicin, cephalothin, cefamandole, penicillin G, ampicillin, tetracycline, erythromycin, or rifampicin against the 3 strains of E coli.

Results—The 3 strains of E coli were susceptible to gentamicin and rifampicin but highly resistant to most of the other antimicrobials tested, except for strain 9061 that was also susceptible to cephalothin but intermediately inhibited by kanamycin and cefamandole. Synergistic growth-inhibitory activity was observed between bLf-lysate and gentamicin against 1 strain of E coli (strain 9062); synergistic bactericidal activity was found between bLf-lysate and rifampicin against all 3 strains of E coli. Moreover, partial synergy was observed between bLf-lysate and kanamycin, gentamicin, cephalothin, or cefamandole against the strains of E coli, but this partial synergistic activity was mostly seen against only 1 of the strains. Little interaction between bLf-lysate and tetracycline, ampicillin, penicillin G, or erythromycin was observed against the clinical strains of E coli.

Conclusions and Clinical Relevance—A combination of bLf-lysate and certain antimicrobials may prove clinically effective against antimicrobial-resistant strains of E coli. (Am J Vet Res 2004;65:131–137)